Xcout Intel
Mestag Therapeutics competitors & alternatives
The 12 closest competitors and alternatives to Mestag Therapeutics among biotechnology companies — ranked by similarity to what Mestag Therapeutics actually does, not by market-cap band.
Subscribe to see Mestag Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Mestag Therapeutics
Mestag Therapeutics is an immunotherapy company focusing on fibroblast-immune biology to address critical unmet needs in inflammatory diseases and oncology. The company operates across hubs including Cambridge, United Kingdom, and Ghent, Belgium.
Mestag Therapeutics at a glance
Mestag Therapeutics is a biotechnology company headquartered in United Kingdom. Its most recent funding round, Seed, raised $40M in March 2026. Xcout tracks 18 named people at Mestag Therapeutics, including Susan Hill (Chief Executive Officer).
Mestag Therapeutics leadership
- Susan HillChief Executive Officer
- Lindsey RolfeChief Medical Officer
- Pascal MerchiersChief Development Officer
- Robert de JongeChief Business Officer
- Ton LogtenbergChair
- Susan HillChief Executive Officer
12 more named people on record for Mestag Therapeutics, with roles, board committees and tenure — see the full roster →
Mestag Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $40M | 5 named | |
| Seed | $45M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Mestag Therapeutics competitors
Ranked by semantic similarity — how close each company is to Mestag Therapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Mission Therapeutics is a drug discovery and development company recognized as a global leader in targeting deubiquitylating enzymes. Founded in 2011, the firm is based at the Babraham Research Campus in Cambridge, United Kingdom.
Biotechnology / Life Science
Engitix is a biotechnology company that utilizes a proprietary platform based on human Extracellular Matrix (ECM) scaffolds to model and study disease biology. The company develops discovery-stage therapeutics targeting fibrosis, inflammation, and solid tumors, and forms partnerships with pharmaceutical and biotech organizations.
Similar biotechnology company
Mesentech Inc. is an active for-profit biotechnology company focused on drug pipelines, therapeutic areas, and proprietary technology platforms. Headquartered in Vancouver, British Columbia, Canada, the company operates with a small team specializing in clinical research and development.
Similar biotechnology company
4F Biotech is a biotechnology firm focused on developing innovative therapeutic approaches, screening platforms, and diagnostic tools to combat fibrosis and inflammatory processes.
Similar biotechnology company
Merus N.V. is a clinical-stage oncology company that discovers and develops antibody treatments for cancer using its proprietary Multiclonics platform. The company serves patients with cancer by advancing innovative therapeutic pipelines. Merus operates as part of Genmab.
Biotech
NanoGhost is a biotechnology company that develops a targeted drug delivery platform using nanovesicles derived from the cell membranes of mesenchymal stem cells. The company serves the medical and pharmaceutical sectors by creating technologies designed to selectively target cancer and sites of inflammation for improved therapeutic delivery.
Similar biotechnology company
PhoreMost Ltd is a Cambridge, United Kingdom-based biotechnology and drug discovery company dedicated to turning scientific breakthroughs into life-changing cancer therapies.
Life Sciences
ImStar Therapeutics Inc. is a biotechnology company headquartered in Vancouver, British Columbia, focused on breakthrough science and drug discovery.
Similar biotechnology company
Vibrant Therapeutics is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts, with operations in China. Founded in July 2019, the firm focuses on revolutionizing protein drug discovery and developing next-generation prodrugs with precise targeting.
Biotech
Werewolf Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing novel therapies that activate the body's immune system to combat cancer. Leveraging its exclusive PREDATOR platform, the company crafts conditionally activated molecules designed to stimulate both adaptive and innate immunity. This strategic approach aims to circumvent the shortcomings often associated with traditional proinflammatory immune treatments. Key among its product pipeline are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule targeting advanced solid tumors, and WTX-330, an Interleukin-12 INDUKINE molecule also designed for conditional activation, intended for advanced or metastatic solid tumors or lymphomas that have relapsed or are refractory. Furthermore, Werewolf Therapeutics is progressing WTX-613, a conditionally activated interferon alpha INDUKINE molecule, for addressing solid tumors and hematologic malignancies. The company was founded in 2017 and operates from its headquarters in Cambridge, Massachusetts.
Biotech
Octant Bio is a biotechnology company that combines next-generation biology, chemistry, and computation to discover and develop precision small molecule therapeutics. The company targets complex cellular mechanisms to address genetic diseases, such as protein misfolding and mistrafficking across various therapeutic areas including genetic disorders, oncology, metabolism, and immunology.
Similar biotechnology company
Matchpoint Therapeutics Inc. discovers and develops precision small molecule medicines utilizing covalent chemistry and chemoproteomics screening to treat immune diseases. The company leverages proprietary screening technologies and machine learning algorithms to expand the druggable proteome and design covalent drug candidates for patients with serious inflammatory and immune conditions.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Mestag Therapeutics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Mestag Therapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →